Cargando…

Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer

BACKGROUND: In early trials, hypersensitivity reactions (HSRs) to paclitaxel were common, thus prompting the administration of antihistamines and corticosteroids before every paclitaxel dose. We tested the safety of omitting corticosteroids after cycle 2 during the paclitaxel portion of the dose‐den...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barroso‐Sousa, Romualdo, Vaz‐Luis, Ines, Di Meglio, Antonio, Hu, Jiani, Li, Tianyu, Rees, Rebecca, Sinclair, Natalie, Milisits, Lindsey, Leone, Jose Pablo, Constantine, Michael, Faggen, Meredith, Briccetti, Frederick, Block, Caroline, Partridge, Ann, Burstein, Harold, Waks, Adrienne G., Tayob, Nabihah, Trippa, Lorenzo, Tolaney, Sara M., Hassett, Michael J., Winer, Eric P., Lin, Nancy U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Breast Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571744/ https://www.ncbi.nlm.nih.gov/pubmed/34472667 http://dx.doi.org/10.1002/onco.13960

Ejemplares similares

Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study
por: Vaz-Luis, Ines, et al.
Publicado: (2020)

A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer
por: Waks, Adrienne G., et al.
Publicado: (2022)

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2021)

Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies
por: Morganti, Stefania, et al.
Publicado: (2023)

Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2022)

Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021)

Factors associated with late risks of breast cancer-specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021)

A Simplified Approach to Breast Reduction Using the Medial Pedicle
por: Hunt, Sarah C, et al.
Publicado: (2022)

Recurrent Extreme Bilateral Gigantomastia Caused by Pseudoangiomatous Stromal Hyperplasia (PASH) Syndrome: A Case Report
por: Parisi, Paola, et al.
Publicado: (2023)

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer
por: Waks, Adrienne G, et al.
Publicado: (2022)

Diffusion-weighted imaging in relation to morphology on dynamic contrast enhancement MRI: the diagnostic value of characterizing non-puerperal mastitis
por: Zhang, Lina, et al.
Publicado: (2017)

Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)
por: Sella, Tal, et al.
Publicado: (2022)

Single Center Oncoplastic Experience and Patient Satisfaction Reported via Patient Reported Outcomes
por: Wang, Xuanji, et al.
Publicado: (2022)

An Evaluation of the Impact of Mental Illness on Postoperative Breast Reconstruction Revision Surgery
por: Saifee, Jessica F., et al.
Publicado: (2023)

Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group
por: Baltzer, Pascal, et al.
Publicado: (2019)

Can We Reach a Consensus on the Appropriate Use of Before and After Photos in Breast Surgery?
por: Valiquette, Chantal R., et al.
Publicado: (2021)

A survey by the European Society of Breast Imaging on the implementation of breast diffusion-weighted imaging in clinical practice
por: Lo Gullo, Roberto, et al.
Publicado: (2022)

Clinical Development of New Antibody–Drug Conjugates in Breast Cancer: To Infinity and Beyond
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2021)

A Phase II Trial of Cabozantinib in Hormone Receptor‐Positive Breast Cancer with Bone Metastases
por: Xu, Jing, et al.
Publicado: (2020)

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
por: Keenan, Tanya E., et al.
Publicado: (2021)

TRLS-03. PHASE II TRIAL OF GDC-0084 IN COMBINATION WITH TRASTUZUMAB FOR PATIENTS WITH HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BCBM)
por: Leone, Jose Pablo, et al.
Publicado: (2019)

Evidence to date: talazoparib in the treatment of breast cancer
por: Exman, Pedro, et al.
Publicado: (2019)

Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions
por: Veltman, J., et al.
Publicado: (2008)

What parameters affect pain in core biopsy?
por: Zografos, George C., et al.
Publicado: (2008)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

Value of tissue harmonic imaging (THI) and contrast harmonic imaging (CHI) in detection and characterisation of breast tumours
por: Clevert, D.- A., et al.
Publicado: (2006)

Computer-aided detection in breast MRI: a systematic review and meta-analysis
por: Dorrius, Monique D., et al.
Publicado: (2011)

Using computer-aided detection in mammography as a decision support
por: Samulski, Maurice, et al.
Publicado: (2010)

Stereotactic large-core needle breast biopsy: analysis of pain and discomfort related to the biopsy procedure
por: Hemmer, Judith M., et al.
Publicado: (2007)

Shear wave elastography for breast masses is highly reproducible
por: Cosgrove, David O., et al.
Publicado: (2011)

Increase in perceived case suspiciousness due to local contrast optimisation in digital screening mammography
por: Visser, Roelant, et al.
Publicado: (2011)

The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging
por: Dorrius, M. D., et al.
Publicado: (2011)

MR-guided breast biopsy at 3T: diagnostic yield of large core needle biopsy compared with vacuum-assisted biopsy
por: Meeuwis, Carla, et al.
Publicado: (2011)

Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review
por: Robertson, Clare, et al.
Publicado: (2011)

Value of the BI-RADS classification in MR-Mammography for diagnosis of benign and malignant breast tumors
por: Sohns, Christian, et al.
Publicado: (2011)

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
por: Fangberget, A., et al.
Publicado: (2010)

Breast cancer detection: radiologists’ performance using mammography with and without automated whole-breast ultrasound
por: Kelly, Kevin M., et al.
Publicado: (2010)

The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool
por: Timmers, J. M. H., et al.
Publicado: (2012)

Feasibility of MRI-guided large-core-needle biopsy of suspiscious breast lesions at 3 T
por: Peters, Nicky H. G. M., et al.
Publicado: (2009)

Computer-aided detection (CAD) for breast MRI: evaluation of efficacy at 3.0 T
por: Meeuwis, Carla, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_81uvdof2cp4ocqjn9urd6r0lgs